Insulin Glargine (Monograph)Play pronunciation Brand names: Basaglar, Lantus, Soliqua 100/33 (combination), Toujeo Drug class: Long-acting Insulins ATC class: A10AB01 VA class: HS501 Chemical name: 21A-Glycine-30Ba-l-arginine-30Bb-l-arginine insulin (human) Molecular formula: C267H404N72O...
导读:甘精胰岛素由赛诺菲(Sanofi)研发,于2000年4月20日获得美国食品药品监督管理局(FDA)批准,2000年6月9日获得欧洲药物管理局(EMA)批准,2003年11月7日获得中国食品药品监督管理局(CFDA)批准,2008年1月30日获得日本医药品医疗器械综合机构(PMDA)批准上市,并由赛诺菲在美国、欧洲、日本和中国市场销售,商品名为Lantus...
Drug class: insulin En español Patient resources Other brands Basaglar, Toujeo, Semglee, Rezvoglar Professional resources Lantus prescribing information Insulin Glargine (AHFS Monograph) Other brands Basaglar, Toujeo SoloStar, Semglee, Rezvoglar Other formulations Lantus Solostar Pen Related treatment ...
甘精胰岛素由赛诺菲(Sanofi)研发,于2000年4月20日获得美国食品药品监督管理局(FDA)批准,2000年6月9日获得欧洲药物管理局(EMA)批准,2003年11月7日获得中国食品药品监督管理局(CFDA)批准,2008年1月30日获得日本医药品医疗器械综合机构(PMDA)批准上市,并由赛诺菲在美国、欧洲、日本和中国市场销售,商品名为Lantus和Toujeo。
甘精胰岛素由赛诺菲(Sanofi)研发,于2000年4月20日获得美国食品药品监督管理局(FDA)批准,2000年6月9日获得欧洲药物管理局(EMA)批准,2003年11月7日获得中国食品药品监督管理局(CFDA)批准,2008年1月30日获得日本医药品医疗器械综合机构(PMDA)批...
甘精胰岛素 英文品名Insulin Glargine 名称来源p-INNList-76,1996;r-INNList-38,1997; 化学表述21A-glycine-30Ba-L-arginine-30Bb-L-arginineinsulin (human) CA登记号160337-95-1 分子式C267H404N72O78S6 结构式 品种类别消化系统>抗糖尿病药>胰岛素类;...
Soliqua (insulin glargine/lixisenatide) - Uses, Side Effects, and More Medically Reviewed by Andrea Wessell, PharmD, BCPS on Sep 09, 2024 | Written by Ami Ishver, PharmD Common Brand Name(s): Soliqua Common Generic Name(s): insulin glargine/lixisenatide Pronunciation: So-lee-kwa Drug C...
Insulin Glargine has minor interactions with at least 76 other drugs. This information does not contain all possible interactions or adverse effects. Visit the RxList Drug Interaction Checker for any drug interactions. Therefore, before using this drug, tell your doctor or pharmacist of all the dru...
Insulin Drug Interactions Examples of Regular InsulinDrug Interactions Drug or Drug ClassEffectRecommendation Beta-blockers(for example,propranolol[Inderal,Inderal LA,Innopran XL],atenolol[Tenormin])Beta-blockers may masksymptoms of hypoglycemiaor prolong hypoglycemia and alter glucosemetabolismAvoid combination...
Insulin Glargine U300 (hereinafter referred to as “Glargine U300”) is a long-acting basal insulin, a concentrated version of Insulin Glargine U100.Compared to Insulin Glargine U100, Glargine U300 has a longer duration of action, lower day-to-day variability, and a reduced risk of hypoglycemia...